Agriculture
Global Gosling Plague Vaccine Market Research Report 2025
- Mar 11, 25
- ID: 54017
- Pages: 77
- Figures: 79
- Views: 16
The global market for Gosling Plague Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gosling Plague Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gosling Plague Vaccine.
The Gosling Plague Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gosling Plague Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gosling Plague Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qingdao Vland Biotech
Harbin Pharmaceutical Group
Sinopharm-Vacbio
JinYu Biotechnology Co., Ltd.
Jilin Zhengye Biological Product
by Type
Live Attenuated Vaccines
Inactivated Vaccines
by Application
Individual Farming
Medium and Large Farms
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gosling Plague Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gosling Plague Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gosling Plague Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gosling Plague Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gosling Plague Vaccine.
The Gosling Plague Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gosling Plague Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gosling Plague Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qingdao Vland Biotech
Harbin Pharmaceutical Group
Sinopharm-Vacbio
JinYu Biotechnology Co., Ltd.
Jilin Zhengye Biological Product
by Type
Live Attenuated Vaccines
Inactivated Vaccines
by Application
Individual Farming
Medium and Large Farms
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gosling Plague Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gosling Plague Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gosling Plague Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 Gosling Plague Vaccine Market Overview
1.1 Product Definition
1.2 Gosling Plague Vaccine by Type
1.2.1 Global Gosling Plague Vaccine Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.3 Gosling Plague Vaccine by Application
1.3.1 Global Gosling Plague Vaccine Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Individual Farming
1.3.3 Medium and Large Farms
1.4 Global Market Growth Prospects
1.4.1 Global Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Gosling Plague Vaccine Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Gosling Plague Vaccine Production Estimates and Forecasts (2020-2031)
1.4.4 Global Gosling Plague Vaccine Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Gosling Plague Vaccine Production Market Share by Manufacturers (2020-2025)
2.2 Global Gosling Plague Vaccine Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Gosling Plague Vaccine, Industry Ranking, 2023 VS 2024
2.4 Global Gosling Plague Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Gosling Plague Vaccine Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Gosling Plague Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gosling Plague Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Gosling Plague Vaccine, Date of Enter into This Industry
2.9 Gosling Plague Vaccine Market Competitive Situation and Trends
2.9.1 Gosling Plague Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Gosling Plague Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gosling Plague Vaccine Production by Region
3.1 Global Gosling Plague Vaccine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Gosling Plague Vaccine Production Value by Region (2020-2031)
3.2.1 Global Gosling Plague Vaccine Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Gosling Plague Vaccine by Region (2026-2031)
3.3 Global Gosling Plague Vaccine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Gosling Plague Vaccine Production Volume by Region (2020-2031)
3.4.1 Global Gosling Plague Vaccine Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Gosling Plague Vaccine by Region (2026-2031)
3.5 Global Gosling Plague Vaccine Market Price Analysis by Region (2020-2025)
3.6 Global Gosling Plague Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
4 Gosling Plague Vaccine Consumption by Region
4.1 Global Gosling Plague Vaccine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Gosling Plague Vaccine Consumption by Region (2020-2031)
4.2.1 Global Gosling Plague Vaccine Consumption by Region (2020-2025)
4.2.2 Global Gosling Plague Vaccine Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Gosling Plague Vaccine Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Gosling Plague Vaccine Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gosling Plague Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Gosling Plague Vaccine Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Gosling Plague Vaccine Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Gosling Plague Vaccine Production by Type (2020-2031)
5.1.1 Global Gosling Plague Vaccine Production by Type (2020-2025)
5.1.2 Global Gosling Plague Vaccine Production by Type (2026-2031)
5.1.3 Global Gosling Plague Vaccine Production Market Share by Type (2020-2031)
5.2 Global Gosling Plague Vaccine Production Value by Type (2020-2031)
5.2.1 Global Gosling Plague Vaccine Production Value by Type (2020-2025)
5.2.2 Global Gosling Plague Vaccine Production Value by Type (2026-2031)
5.2.3 Global Gosling Plague Vaccine Production Value Market Share by Type (2020-2031)
5.3 Global Gosling Plague Vaccine Price by Type (2020-2031)
6 Segment by Application
6.1 Global Gosling Plague Vaccine Production by Application (2020-2031)
6.1.1 Global Gosling Plague Vaccine Production by Application (2020-2025)
6.1.2 Global Gosling Plague Vaccine Production by Application (2026-2031)
6.1.3 Global Gosling Plague Vaccine Production Market Share by Application (2020-2031)
6.2 Global Gosling Plague Vaccine Production Value by Application (2020-2031)
6.2.1 Global Gosling Plague Vaccine Production Value by Application (2020-2025)
6.2.2 Global Gosling Plague Vaccine Production Value by Application (2026-2031)
6.2.3 Global Gosling Plague Vaccine Production Value Market Share by Application (2020-2031)
6.3 Global Gosling Plague Vaccine Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Qingdao Vland Biotech
7.1.1 Qingdao Vland Biotech Gosling Plague Vaccine Company Information
7.1.2 Qingdao Vland Biotech Gosling Plague Vaccine Product Portfolio
7.1.3 Qingdao Vland Biotech Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Qingdao Vland Biotech Main Business and Markets Served
7.1.5 Qingdao Vland Biotech Recent Developments/Updates
7.2 Harbin Pharmaceutical Group
7.2.1 Harbin Pharmaceutical Group Gosling Plague Vaccine Company Information
7.2.2 Harbin Pharmaceutical Group Gosling Plague Vaccine Product Portfolio
7.2.3 Harbin Pharmaceutical Group Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Harbin Pharmaceutical Group Main Business and Markets Served
7.2.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.3 Sinopharm-Vacbio
7.3.1 Sinopharm-Vacbio Gosling Plague Vaccine Company Information
7.3.2 Sinopharm-Vacbio Gosling Plague Vaccine Product Portfolio
7.3.3 Sinopharm-Vacbio Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Sinopharm-Vacbio Main Business and Markets Served
7.3.5 Sinopharm-Vacbio Recent Developments/Updates
7.4 JinYu Biotechnology Co., Ltd.
7.4.1 JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Company Information
7.4.2 JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Product Portfolio
7.4.3 JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.4.4 JinYu Biotechnology Co., Ltd. Main Business and Markets Served
7.4.5 JinYu Biotechnology Co., Ltd. Recent Developments/Updates
7.5 Jilin Zhengye Biological Product
7.5.1 Jilin Zhengye Biological Product Gosling Plague Vaccine Company Information
7.5.2 Jilin Zhengye Biological Product Gosling Plague Vaccine Product Portfolio
7.5.3 Jilin Zhengye Biological Product Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Jilin Zhengye Biological Product Main Business and Markets Served
7.5.5 Jilin Zhengye Biological Product Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gosling Plague Vaccine Industry Chain Analysis
8.2 Gosling Plague Vaccine Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gosling Plague Vaccine Production Mode & Process Analysis
8.4 Gosling Plague Vaccine Sales and Marketing
8.4.1 Gosling Plague Vaccine Sales Channels
8.4.2 Gosling Plague Vaccine Distributors
8.5 Gosling Plague Vaccine Customer Analysis
9 Gosling Plague Vaccine Market Dynamics
9.1 Gosling Plague Vaccine Industry Trends
9.2 Gosling Plague Vaccine Market Drivers
9.3 Gosling Plague Vaccine Market Challenges
9.4 Gosling Plague Vaccine Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Gosling Plague Vaccine by Type
1.2.1 Global Gosling Plague Vaccine Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.3 Gosling Plague Vaccine by Application
1.3.1 Global Gosling Plague Vaccine Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Individual Farming
1.3.3 Medium and Large Farms
1.4 Global Market Growth Prospects
1.4.1 Global Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Gosling Plague Vaccine Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Gosling Plague Vaccine Production Estimates and Forecasts (2020-2031)
1.4.4 Global Gosling Plague Vaccine Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Gosling Plague Vaccine Production Market Share by Manufacturers (2020-2025)
2.2 Global Gosling Plague Vaccine Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Gosling Plague Vaccine, Industry Ranking, 2023 VS 2024
2.4 Global Gosling Plague Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Gosling Plague Vaccine Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Gosling Plague Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gosling Plague Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Gosling Plague Vaccine, Date of Enter into This Industry
2.9 Gosling Plague Vaccine Market Competitive Situation and Trends
2.9.1 Gosling Plague Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Gosling Plague Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gosling Plague Vaccine Production by Region
3.1 Global Gosling Plague Vaccine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Gosling Plague Vaccine Production Value by Region (2020-2031)
3.2.1 Global Gosling Plague Vaccine Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Gosling Plague Vaccine by Region (2026-2031)
3.3 Global Gosling Plague Vaccine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Gosling Plague Vaccine Production Volume by Region (2020-2031)
3.4.1 Global Gosling Plague Vaccine Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Gosling Plague Vaccine by Region (2026-2031)
3.5 Global Gosling Plague Vaccine Market Price Analysis by Region (2020-2025)
3.6 Global Gosling Plague Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Gosling Plague Vaccine Production Value Estimates and Forecasts (2020-2031)
4 Gosling Plague Vaccine Consumption by Region
4.1 Global Gosling Plague Vaccine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Gosling Plague Vaccine Consumption by Region (2020-2031)
4.2.1 Global Gosling Plague Vaccine Consumption by Region (2020-2025)
4.2.2 Global Gosling Plague Vaccine Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Gosling Plague Vaccine Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Gosling Plague Vaccine Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gosling Plague Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Gosling Plague Vaccine Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Gosling Plague Vaccine Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Gosling Plague Vaccine Production by Type (2020-2031)
5.1.1 Global Gosling Plague Vaccine Production by Type (2020-2025)
5.1.2 Global Gosling Plague Vaccine Production by Type (2026-2031)
5.1.3 Global Gosling Plague Vaccine Production Market Share by Type (2020-2031)
5.2 Global Gosling Plague Vaccine Production Value by Type (2020-2031)
5.2.1 Global Gosling Plague Vaccine Production Value by Type (2020-2025)
5.2.2 Global Gosling Plague Vaccine Production Value by Type (2026-2031)
5.2.3 Global Gosling Plague Vaccine Production Value Market Share by Type (2020-2031)
5.3 Global Gosling Plague Vaccine Price by Type (2020-2031)
6 Segment by Application
6.1 Global Gosling Plague Vaccine Production by Application (2020-2031)
6.1.1 Global Gosling Plague Vaccine Production by Application (2020-2025)
6.1.2 Global Gosling Plague Vaccine Production by Application (2026-2031)
6.1.3 Global Gosling Plague Vaccine Production Market Share by Application (2020-2031)
6.2 Global Gosling Plague Vaccine Production Value by Application (2020-2031)
6.2.1 Global Gosling Plague Vaccine Production Value by Application (2020-2025)
6.2.2 Global Gosling Plague Vaccine Production Value by Application (2026-2031)
6.2.3 Global Gosling Plague Vaccine Production Value Market Share by Application (2020-2031)
6.3 Global Gosling Plague Vaccine Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Qingdao Vland Biotech
7.1.1 Qingdao Vland Biotech Gosling Plague Vaccine Company Information
7.1.2 Qingdao Vland Biotech Gosling Plague Vaccine Product Portfolio
7.1.3 Qingdao Vland Biotech Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Qingdao Vland Biotech Main Business and Markets Served
7.1.5 Qingdao Vland Biotech Recent Developments/Updates
7.2 Harbin Pharmaceutical Group
7.2.1 Harbin Pharmaceutical Group Gosling Plague Vaccine Company Information
7.2.2 Harbin Pharmaceutical Group Gosling Plague Vaccine Product Portfolio
7.2.3 Harbin Pharmaceutical Group Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Harbin Pharmaceutical Group Main Business and Markets Served
7.2.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.3 Sinopharm-Vacbio
7.3.1 Sinopharm-Vacbio Gosling Plague Vaccine Company Information
7.3.2 Sinopharm-Vacbio Gosling Plague Vaccine Product Portfolio
7.3.3 Sinopharm-Vacbio Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Sinopharm-Vacbio Main Business and Markets Served
7.3.5 Sinopharm-Vacbio Recent Developments/Updates
7.4 JinYu Biotechnology Co., Ltd.
7.4.1 JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Company Information
7.4.2 JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Product Portfolio
7.4.3 JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.4.4 JinYu Biotechnology Co., Ltd. Main Business and Markets Served
7.4.5 JinYu Biotechnology Co., Ltd. Recent Developments/Updates
7.5 Jilin Zhengye Biological Product
7.5.1 Jilin Zhengye Biological Product Gosling Plague Vaccine Company Information
7.5.2 Jilin Zhengye Biological Product Gosling Plague Vaccine Product Portfolio
7.5.3 Jilin Zhengye Biological Product Gosling Plague Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Jilin Zhengye Biological Product Main Business and Markets Served
7.5.5 Jilin Zhengye Biological Product Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gosling Plague Vaccine Industry Chain Analysis
8.2 Gosling Plague Vaccine Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gosling Plague Vaccine Production Mode & Process Analysis
8.4 Gosling Plague Vaccine Sales and Marketing
8.4.1 Gosling Plague Vaccine Sales Channels
8.4.2 Gosling Plague Vaccine Distributors
8.5 Gosling Plague Vaccine Customer Analysis
9 Gosling Plague Vaccine Market Dynamics
9.1 Gosling Plague Vaccine Industry Trends
9.2 Gosling Plague Vaccine Market Drivers
9.3 Gosling Plague Vaccine Market Challenges
9.4 Gosling Plague Vaccine Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Gosling Plague Vaccine Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Gosling Plague Vaccine Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Gosling Plague Vaccine Production Capacity (M Doses) by Manufacturers in 2024
Table 4. Global Gosling Plague Vaccine Production by Manufacturers (2020-2025) & (M Doses)
Table 5. Global Gosling Plague Vaccine Production Market Share by Manufacturers (2020-2025)
Table 6. Global Gosling Plague Vaccine Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Gosling Plague Vaccine Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Gosling Plague Vaccine, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Gosling Plague Vaccine as of 2024)
Table 10. Global Market Gosling Plague Vaccine Average Price by Manufacturers (US$/K Doses) & (2020-2025)
Table 11. Global Key Manufacturers of Gosling Plague Vaccine, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Gosling Plague Vaccine, Product Offered and Application
Table 13. Global Key Manufacturers of Gosling Plague Vaccine, Date of Enter into This Industry
Table 14. Global Gosling Plague Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Gosling Plague Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Gosling Plague Vaccine Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Gosling Plague Vaccine Production Value Market Share by Region (2020-2025)
Table 19. Global Gosling Plague Vaccine Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Gosling Plague Vaccine Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Gosling Plague Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 22. Global Gosling Plague Vaccine Production (M Doses) by Region (2020-2025)
Table 23. Global Gosling Plague Vaccine Production Market Share by Region (2020-2025)
Table 24. Global Gosling Plague Vaccine Production (M Doses) Forecast by Region (2026-2031)
Table 25. Global Gosling Plague Vaccine Production Market Share Forecast by Region (2026-2031)
Table 26. Global Gosling Plague Vaccine Market Average Price (US$/K Doses) by Region (2020-2025)
Table 27. Global Gosling Plague Vaccine Market Average Price (US$/K Doses) by Region (2026-2031)
Table 28. Global Gosling Plague Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 29. Global Gosling Plague Vaccine Consumption by Region (2020-2025) & (M Doses)
Table 30. Global Gosling Plague Vaccine Consumption Market Share by Region (2020-2025)
Table 31. Global Gosling Plague Vaccine Forecasted Consumption by Region (2026-2031) & (M Doses)
Table 32. Global Gosling Plague Vaccine Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 34. North America Gosling Plague Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 35. North America Gosling Plague Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 36. Europe Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 37. Europe Gosling Plague Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 38. Europe Gosling Plague Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 39. Asia Pacific Gosling Plague Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 40. Asia Pacific Gosling Plague Vaccine Consumption by Region (2020-2025) & (M Doses)
Table 41. Asia Pacific Gosling Plague Vaccine Consumption by Region (2026-2031) & (M Doses)
Table 42. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 43. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 44. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 45. Global Gosling Plague Vaccine Production (M Doses) by Type (2020-2025)
Table 46. Global Gosling Plague Vaccine Production (M Doses) by Type (2026-2031)
Table 47. Global Gosling Plague Vaccine Production Market Share by Type (2020-2025)
Table 48. Global Gosling Plague Vaccine Production Market Share by Type (2026-2031)
Table 49. Global Gosling Plague Vaccine Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Gosling Plague Vaccine Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Gosling Plague Vaccine Production Value Market Share by Type (2020-2025)
Table 52. Global Gosling Plague Vaccine Production Value Market Share by Type (2026-2031)
Table 53. Global Gosling Plague Vaccine Price (US$/K Doses) by Type (2020-2025)
Table 54. Global Gosling Plague Vaccine Price (US$/K Doses) by Type (2026-2031)
Table 55. Global Gosling Plague Vaccine Production (M Doses) by Application (2020-2025)
Table 56. Global Gosling Plague Vaccine Production (M Doses) by Application (2026-2031)
Table 57. Global Gosling Plague Vaccine Production Market Share by Application (2020-2025)
Table 58. Global Gosling Plague Vaccine Production Market Share by Application (2026-2031)
Table 59. Global Gosling Plague Vaccine Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Gosling Plague Vaccine Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Gosling Plague Vaccine Production Value Market Share by Application (2020-2025)
Table 62. Global Gosling Plague Vaccine Production Value Market Share by Application (2026-2031)
Table 63. Global Gosling Plague Vaccine Price (US$/K Doses) by Application (2020-2025)
Table 64. Global Gosling Plague Vaccine Price (US$/K Doses) by Application (2026-2031)
Table 65. Qingdao Vland Biotech Gosling Plague Vaccine Company Information
Table 66. Qingdao Vland Biotech Gosling Plague Vaccine Specification and Application
Table 67. Qingdao Vland Biotech Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 68. Qingdao Vland Biotech Main Business and Markets Served
Table 69. Qingdao Vland Biotech Recent Developments/Updates
Table 70. Harbin Pharmaceutical Group Gosling Plague Vaccine Company Information
Table 71. Harbin Pharmaceutical Group Gosling Plague Vaccine Specification and Application
Table 72. Harbin Pharmaceutical Group Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 73. Harbin Pharmaceutical Group Main Business and Markets Served
Table 74. Harbin Pharmaceutical Group Recent Developments/Updates
Table 75. Sinopharm-Vacbio Gosling Plague Vaccine Company Information
Table 76. Sinopharm-Vacbio Gosling Plague Vaccine Specification and Application
Table 77. Sinopharm-Vacbio Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 78. Sinopharm-Vacbio Main Business and Markets Served
Table 79. Sinopharm-Vacbio Recent Developments/Updates
Table 80. JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Company Information
Table 81. JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Specification and Application
Table 82. JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 83. JinYu Biotechnology Co., Ltd. Main Business and Markets Served
Table 84. JinYu Biotechnology Co., Ltd. Recent Developments/Updates
Table 85. Jilin Zhengye Biological Product Gosling Plague Vaccine Company Information
Table 86. Jilin Zhengye Biological Product Gosling Plague Vaccine Specification and Application
Table 87. Jilin Zhengye Biological Product Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 88. Jilin Zhengye Biological Product Main Business and Markets Served
Table 89. Jilin Zhengye Biological Product Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Gosling Plague Vaccine Distributors List
Table 93. Gosling Plague Vaccine Customers List
Table 94. Gosling Plague Vaccine Market Trends
Table 95. Gosling Plague Vaccine Market Drivers
Table 96. Gosling Plague Vaccine Market Challenges
Table 97. Gosling Plague Vaccine Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gosling Plague Vaccine
Figure 2. Global Gosling Plague Vaccine Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Gosling Plague Vaccine Market Share by Type: 2024 VS 2031
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Global Gosling Plague Vaccine Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Gosling Plague Vaccine Market Share by Application: 2024 VS 2031
Figure 8. Individual Farming
Figure 9. Medium and Large Farms
Figure 10. Global Gosling Plague Vaccine Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Gosling Plague Vaccine Production Value (US$ Million) & (2020-2031)
Figure 12. Global Gosling Plague Vaccine Production Capacity (M Doses) & (2020-2031)
Figure 13. Global Gosling Plague Vaccine Production (M Doses) & (2020-2031)
Figure 14. Global Gosling Plague Vaccine Average Price (US$/K Doses) & (2020-2031)
Figure 15. Gosling Plague Vaccine Report Years Considered
Figure 16. Gosling Plague Vaccine Production Share by Manufacturers in 2024
Figure 17. Global Gosling Plague Vaccine Production Value Share by Manufacturers (2024)
Figure 18. Gosling Plague Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. The Global 5 and 10 Largest Players: Market Share by Gosling Plague Vaccine Revenue in 2024
Figure 20. Global Gosling Plague Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 21. Global Gosling Plague Vaccine Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 22. Global Gosling Plague Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 23. Global Gosling Plague Vaccine Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 24. North America Gosling Plague Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Gosling Plague Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. China Gosling Plague Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Gosling Plague Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Global Gosling Plague Vaccine Consumption by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 29. Global Gosling Plague Vaccine Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 30. North America Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 31. North America Gosling Plague Vaccine Consumption Market Share by Country (2020-2031)
Figure 32. U.S. Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 33. Canada Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 34. Europe Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 35. Europe Gosling Plague Vaccine Consumption Market Share by Country (2020-2031)
Figure 36. Germany Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 37. France Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 38. U.K. Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 39. Italy Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 40. Russia Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 41. Asia Pacific Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 42. Asia Pacific Gosling Plague Vaccine Consumption Market Share by Region (2020-2031)
Figure 43. China Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 44. Japan Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 45. South Korea Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 46. China Taiwan Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 47. Southeast Asia Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 48. India Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 49. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 50. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption Market Share by Country (2020-2031)
Figure 51. Mexico Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 52. Brazil Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 53. Turkey Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 54. GCC Countries Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 55. Global Production Market Share of Gosling Plague Vaccine by Type (2020-2031)
Figure 56. Global Production Value Market Share of Gosling Plague Vaccine by Type (2020-2031)
Figure 57. Global Gosling Plague Vaccine Price (US$/K Doses) by Type (2020-2031)
Figure 58. Global Production Market Share of Gosling Plague Vaccine by Application (2020-2031)
Figure 59. Global Production Value Market Share of Gosling Plague Vaccine by Application (2020-2031)
Figure 60. Global Gosling Plague Vaccine Price (US$/K Doses) by Application (2020-2031)
Figure 61. Gosling Plague Vaccine Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Table 1. Global Gosling Plague Vaccine Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Gosling Plague Vaccine Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Gosling Plague Vaccine Production Capacity (M Doses) by Manufacturers in 2024
Table 4. Global Gosling Plague Vaccine Production by Manufacturers (2020-2025) & (M Doses)
Table 5. Global Gosling Plague Vaccine Production Market Share by Manufacturers (2020-2025)
Table 6. Global Gosling Plague Vaccine Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Gosling Plague Vaccine Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Gosling Plague Vaccine, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Gosling Plague Vaccine as of 2024)
Table 10. Global Market Gosling Plague Vaccine Average Price by Manufacturers (US$/K Doses) & (2020-2025)
Table 11. Global Key Manufacturers of Gosling Plague Vaccine, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Gosling Plague Vaccine, Product Offered and Application
Table 13. Global Key Manufacturers of Gosling Plague Vaccine, Date of Enter into This Industry
Table 14. Global Gosling Plague Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Gosling Plague Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Gosling Plague Vaccine Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Gosling Plague Vaccine Production Value Market Share by Region (2020-2025)
Table 19. Global Gosling Plague Vaccine Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Gosling Plague Vaccine Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Gosling Plague Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 22. Global Gosling Plague Vaccine Production (M Doses) by Region (2020-2025)
Table 23. Global Gosling Plague Vaccine Production Market Share by Region (2020-2025)
Table 24. Global Gosling Plague Vaccine Production (M Doses) Forecast by Region (2026-2031)
Table 25. Global Gosling Plague Vaccine Production Market Share Forecast by Region (2026-2031)
Table 26. Global Gosling Plague Vaccine Market Average Price (US$/K Doses) by Region (2020-2025)
Table 27. Global Gosling Plague Vaccine Market Average Price (US$/K Doses) by Region (2026-2031)
Table 28. Global Gosling Plague Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 29. Global Gosling Plague Vaccine Consumption by Region (2020-2025) & (M Doses)
Table 30. Global Gosling Plague Vaccine Consumption Market Share by Region (2020-2025)
Table 31. Global Gosling Plague Vaccine Forecasted Consumption by Region (2026-2031) & (M Doses)
Table 32. Global Gosling Plague Vaccine Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 34. North America Gosling Plague Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 35. North America Gosling Plague Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 36. Europe Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 37. Europe Gosling Plague Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 38. Europe Gosling Plague Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 39. Asia Pacific Gosling Plague Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 40. Asia Pacific Gosling Plague Vaccine Consumption by Region (2020-2025) & (M Doses)
Table 41. Asia Pacific Gosling Plague Vaccine Consumption by Region (2026-2031) & (M Doses)
Table 42. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 43. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 44. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 45. Global Gosling Plague Vaccine Production (M Doses) by Type (2020-2025)
Table 46. Global Gosling Plague Vaccine Production (M Doses) by Type (2026-2031)
Table 47. Global Gosling Plague Vaccine Production Market Share by Type (2020-2025)
Table 48. Global Gosling Plague Vaccine Production Market Share by Type (2026-2031)
Table 49. Global Gosling Plague Vaccine Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Gosling Plague Vaccine Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Gosling Plague Vaccine Production Value Market Share by Type (2020-2025)
Table 52. Global Gosling Plague Vaccine Production Value Market Share by Type (2026-2031)
Table 53. Global Gosling Plague Vaccine Price (US$/K Doses) by Type (2020-2025)
Table 54. Global Gosling Plague Vaccine Price (US$/K Doses) by Type (2026-2031)
Table 55. Global Gosling Plague Vaccine Production (M Doses) by Application (2020-2025)
Table 56. Global Gosling Plague Vaccine Production (M Doses) by Application (2026-2031)
Table 57. Global Gosling Plague Vaccine Production Market Share by Application (2020-2025)
Table 58. Global Gosling Plague Vaccine Production Market Share by Application (2026-2031)
Table 59. Global Gosling Plague Vaccine Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Gosling Plague Vaccine Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Gosling Plague Vaccine Production Value Market Share by Application (2020-2025)
Table 62. Global Gosling Plague Vaccine Production Value Market Share by Application (2026-2031)
Table 63. Global Gosling Plague Vaccine Price (US$/K Doses) by Application (2020-2025)
Table 64. Global Gosling Plague Vaccine Price (US$/K Doses) by Application (2026-2031)
Table 65. Qingdao Vland Biotech Gosling Plague Vaccine Company Information
Table 66. Qingdao Vland Biotech Gosling Plague Vaccine Specification and Application
Table 67. Qingdao Vland Biotech Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 68. Qingdao Vland Biotech Main Business and Markets Served
Table 69. Qingdao Vland Biotech Recent Developments/Updates
Table 70. Harbin Pharmaceutical Group Gosling Plague Vaccine Company Information
Table 71. Harbin Pharmaceutical Group Gosling Plague Vaccine Specification and Application
Table 72. Harbin Pharmaceutical Group Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 73. Harbin Pharmaceutical Group Main Business and Markets Served
Table 74. Harbin Pharmaceutical Group Recent Developments/Updates
Table 75. Sinopharm-Vacbio Gosling Plague Vaccine Company Information
Table 76. Sinopharm-Vacbio Gosling Plague Vaccine Specification and Application
Table 77. Sinopharm-Vacbio Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 78. Sinopharm-Vacbio Main Business and Markets Served
Table 79. Sinopharm-Vacbio Recent Developments/Updates
Table 80. JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Company Information
Table 81. JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Specification and Application
Table 82. JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 83. JinYu Biotechnology Co., Ltd. Main Business and Markets Served
Table 84. JinYu Biotechnology Co., Ltd. Recent Developments/Updates
Table 85. Jilin Zhengye Biological Product Gosling Plague Vaccine Company Information
Table 86. Jilin Zhengye Biological Product Gosling Plague Vaccine Specification and Application
Table 87. Jilin Zhengye Biological Product Gosling Plague Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 88. Jilin Zhengye Biological Product Main Business and Markets Served
Table 89. Jilin Zhengye Biological Product Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Gosling Plague Vaccine Distributors List
Table 93. Gosling Plague Vaccine Customers List
Table 94. Gosling Plague Vaccine Market Trends
Table 95. Gosling Plague Vaccine Market Drivers
Table 96. Gosling Plague Vaccine Market Challenges
Table 97. Gosling Plague Vaccine Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gosling Plague Vaccine
Figure 2. Global Gosling Plague Vaccine Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Gosling Plague Vaccine Market Share by Type: 2024 VS 2031
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Global Gosling Plague Vaccine Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Gosling Plague Vaccine Market Share by Application: 2024 VS 2031
Figure 8. Individual Farming
Figure 9. Medium and Large Farms
Figure 10. Global Gosling Plague Vaccine Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Gosling Plague Vaccine Production Value (US$ Million) & (2020-2031)
Figure 12. Global Gosling Plague Vaccine Production Capacity (M Doses) & (2020-2031)
Figure 13. Global Gosling Plague Vaccine Production (M Doses) & (2020-2031)
Figure 14. Global Gosling Plague Vaccine Average Price (US$/K Doses) & (2020-2031)
Figure 15. Gosling Plague Vaccine Report Years Considered
Figure 16. Gosling Plague Vaccine Production Share by Manufacturers in 2024
Figure 17. Global Gosling Plague Vaccine Production Value Share by Manufacturers (2024)
Figure 18. Gosling Plague Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. The Global 5 and 10 Largest Players: Market Share by Gosling Plague Vaccine Revenue in 2024
Figure 20. Global Gosling Plague Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 21. Global Gosling Plague Vaccine Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 22. Global Gosling Plague Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 23. Global Gosling Plague Vaccine Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 24. North America Gosling Plague Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Gosling Plague Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. China Gosling Plague Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Gosling Plague Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Global Gosling Plague Vaccine Consumption by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 29. Global Gosling Plague Vaccine Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 30. North America Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 31. North America Gosling Plague Vaccine Consumption Market Share by Country (2020-2031)
Figure 32. U.S. Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 33. Canada Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 34. Europe Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 35. Europe Gosling Plague Vaccine Consumption Market Share by Country (2020-2031)
Figure 36. Germany Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 37. France Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 38. U.K. Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 39. Italy Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 40. Russia Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 41. Asia Pacific Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 42. Asia Pacific Gosling Plague Vaccine Consumption Market Share by Region (2020-2031)
Figure 43. China Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 44. Japan Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 45. South Korea Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 46. China Taiwan Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 47. Southeast Asia Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 48. India Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 49. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 50. Latin America, Middle East & Africa Gosling Plague Vaccine Consumption Market Share by Country (2020-2031)
Figure 51. Mexico Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 52. Brazil Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 53. Turkey Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 54. GCC Countries Gosling Plague Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 55. Global Production Market Share of Gosling Plague Vaccine by Type (2020-2031)
Figure 56. Global Production Value Market Share of Gosling Plague Vaccine by Type (2020-2031)
Figure 57. Global Gosling Plague Vaccine Price (US$/K Doses) by Type (2020-2031)
Figure 58. Global Production Market Share of Gosling Plague Vaccine by Application (2020-2031)
Figure 59. Global Production Value Market Share of Gosling Plague Vaccine by Application (2020-2031)
Figure 60. Global Gosling Plague Vaccine Price (US$/K Doses) by Application (2020-2031)
Figure 61. Gosling Plague Vaccine Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oil in Water Monitoring Sensor Market Research Report 2025
Jun 06, 25
Global Large LCD Display Market Research Report 2025
Jun 06, 25
Global Commercial LCD Monitor Market Research Report 2025
Jun 06, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232